Senior Director, UMass Memorial Health
BIOGRAPHY
APR 10, 2024 12:00 PM PDT
Unveiling Real World Impact
Assessing the Implementation, Clinical Utility, and Economic Outcomes of A Novel Assay in Rapidly Distinguishing the Etiology of Acute Bacterial and Co-Infections from Viral Infection
Speaker
Event Date & Time
Date: April 10, 2024
Time: 12:00 PM (PST), 3:00 PM (EST), 8:00 PM (CET)
Abstract
This webinar seeks to introduce novel innovative testing based on the computational integration of three host immune response proteins, TRAIL, IP-10, and CRP to differentiate bacterial from viral infections and for identification of coinfection. The assay is approved for use in pediatric and adult patients with suspected acute infection with symptoms for seven days or less, presenting to the emergency department or urgent care center, and samples collected at hospital admission.
Identifying and managing acute infections in the Emergency Department and upon admission to the hospital can be challenging for many reasons. The host immune response technology in the assay offers advantages in accuracy, and faster results, and are not dependent on identification of infection site. This session will explore the implementation journey, clinical utilization, and economic impact of the assay. Performance data and selected case studies will be discussed using novel technology that quickly and accurately identifies the etiology of acute infections.
Learning Objectives
- Clarify the implementation journey, including challenges, of a new technology in a real-world clinical setting
- Identify the clinical, operational, and economic impact of novel assays in real-world settings
- Examine selected case studies to identify potential assay application
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...